| Serial Number | 90311854 |
| Word Mark | RAKUTEN MEDICAL |
| Filing Date | Wednesday, November 11, 2020 |
| Status | 811 - SU - EXAMINER'S AMENDMENT - MAILED |
| Status Date | Thursday, August 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 15, 2021 |
| Goods and Services | Educational services, providing training in the field of medicines, medical devices, pharmaceuticals, clinical trials and health care; Teaching and training services, namely, courses, classes, lessons and seminars in the field of medicines, pharmaceuticals and health care; Arranging, conducting and organization of congresses, conferences, conventions and symposiums in the field of medicines, pharmaceuticals and health care; Educational services, namely, providing classes, seminars, and lectures, all in the field of the diagnosis and treatment of cancer; education in the nature of classes, seminars, and training in the oncology field |
| Goods and Services | Compilation of statistical data relating to medical research for business purposes |
| Goods and Services | Medical services; Medical information; Providing medical information from a web site; Medical testing for diagnostic or treatment purposes; Medical treatment services; Medical care services; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical services in the field of oncology; Medical consultation; Medical advisory services; Compilation of medical reports, namely, medical reporting services; Issuing of medical reports, namely, medical reporting services; Medical and healthcare clinics; Medical assistance; Healthcare services; Rental of medical machines and apparatus; Consultancy and information services relating to the diagnostic, prophylactic, and therapeutic properties of medical products; Providing information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; Counselling services, namely, medical counselling for patients diagnosed with cancer; Information services in the field of diagnosing and treating cancer; Providing online information services, namely, prescription drug information regarding diagnostic, prophylactic, and therapeutic properties; Providing information in the field of medicine; Providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via a website; Providing information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via an online searchable database; Medical diagnostic testing and reporting services; Genetic testing for diagnostic and treatment purposes; Providing healthcare information regarding cancer drugs and cancer treatment; Maintaining personal medical history records and files |
| NOT AVAILABLE | "MEDICAL" |
| Goods and Services | Testing and research on medical treatment methods and techniques; Provision of medical and scientific research information on clinical trials; Research and development in the field of immunology; Testing and research on pharmaceuticals; Medical and pharmacological research services and clinical trials for others; Research, development, and consultation related thereto in the field of medicine; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical drug development services; Medical laboratories; Design and development of medical technology; Scientific, biological and medical research; Conducting clinical trials for others |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, January 10, 2023 |
| First Use In Commerce Date | Tuesday, January 10, 2023 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 041 |
| First Use Anywhere Date | Tuesday, January 10, 2023 |
| First Use In Commerce Date | Tuesday, January 10, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, March 1, 2019 |
| First Use In Commerce Date | Friday, March 1, 2019 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, March 1, 2019 |
| First Use In Commerce Date | Friday, March 1, 2019 |
| Party Name | RAKUTEN GROUP, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SETAGAYA-KU, TOKYO 158-0094 JP |
| Party Name | RAKUTEN GROUP, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SETAGAYA-KU, TOKYO 158-0094 JP |
| Party Name | Rakuten, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Setagaya-ku, Tokyo 158-0094 JP |
| Event Date | Event Description |
| Monday, January 11, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 14, 2020 | NEW APPLICATION ENTERED |
| Wednesday, April 14, 2021 | ASSIGNED TO EXAMINER |
| Friday, April 23, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 23, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, April 23, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 23, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 23, 2021 | SUSPENSION LETTER WRITTEN |
| Friday, April 23, 2021 | LETTER OF SUSPENSION E-MAILED |
| Friday, April 23, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 5, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, May 10, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 15, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 15, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 24, 2021 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Monday, July 19, 2021 | ASSIGNED TO PETITION STAFF |
| Tuesday, July 20, 2021 | POST PUBLICATION AMENDMENT - ENTERED |
| Tuesday, August 10, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 20, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 20, 2022 | SOU EXTENSION 1 FILED |
| Thursday, January 20, 2022 | SOU EXTENSION 1 GRANTED |
| Saturday, January 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 5, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 5, 2022 | SOU EXTENSION 2 FILED |
| Friday, August 5, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, August 9, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 23, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 23, 2023 | SOU EXTENSION 3 FILED |
| Monday, January 23, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, January 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 8, 2023 | SOU EXTENSION 4 FILED |
| Tuesday, August 8, 2023 | SOU EXTENSION 4 GRANTED |
| Thursday, August 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 26, 2023 | ASSIGNED TO EXAMINER |
| Monday, February 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 5, 2024 | SOU EXTENSION 5 FILED |
| Wednesday, February 21, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 21, 2024 | SOU EXTENSION 5 GRANTED |
| Thursday, February 22, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 5, 2024 | USE AMENDMENT FILED |
| Monday, August 5, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, August 7, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, September 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Thursday, November 14, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, September 9, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, November 14, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 14, 2024 | ASSIGNED TO LIE |
| Wednesday, May 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 14, 2025 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, May 14, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, August 28, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 28, 2025 | SU-EXAMINER'S AMENDMENT WRITTEN |
| Thursday, August 28, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 28, 2025 | EXAMINER'S AMENDMENT ENTERED |